Articles / Ozempic drought continues
Ozempic supply will be limited for the rest of this year and throughout 2024, as demand has accelerated in recent months, the Therapeutic Goods Administration announced last week.
After consultation with the Ozempic Medicine Shortage Action Group, the TGA is advising prescribers:
“When deciding whether to continue treatment consult the appropriate prescribing guidelines. Prioritise patients for whom Ozempic will have the most clinical impact, including patients already stabilised on the medicine and without other treatment options,” the TGA advised.
Ozempic’s TGA-approved indication is for the management of type 2 diabetes not adequately managed by other medications, in conjunction with diet and exercise.
Manufacturer Novo Nordisk said that very limited new supplies of Ozempic 0.25/0.5 mg will be available before the end of 2023 and supply of all strengths of Ozempic will be intermittent for the rest of 2023 and throughout 2024.
Ozempic is in shortage worldwide and the issue is not limited to Australia.
Novo Nordisk has said they are increasing manufacturing capacity, but is not known when the medicine will be available in sufficient quantities to meet the ongoing high demand.
Dementia – Which Test do I Use?
Irregular Periods in Adolescents – It's Not Always PCOS
Management of Mild to Moderate Acne
COPD Cases
Strongly agree
Somewhat agree
Neutral
Somewhat disagree
Strongly disagree
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.